Lee Feigert, PharmD, MSPBA

With ongoing growth across the board, plan sponsors are continuously searching for ways to minimize the impact on their bottom line.

There are currently firms working to use artificial intelligence in hopes that it could contribute to minimizing the impact of the opioid epidemic.

The world is rapidly moving towards the adoption and seamless integration of artificial intelligence (AI), including machine learning as a subset of AI, throughout our daily lives.